These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 37693229)

  • 1. Clinical Use of Oral Opioid Therapy for Dyspnea in Patients With Advanced Heart Failure　- A Single-Center Retrospective Study.
    Nakamura T; Nakamura M; Kai M; Shibasaki Y; Tomita H; Watabe M; Yokokura H; Momomura SI
    Circ Rep; 2023 Sep; 5(9):351-357. PubMed ID: 37693229
    [No Abstract]   [Full Text] [Related]  

  • 2. Experience of morphine therapy for refractory dyspnea as palliative care in advanced heart failure patients.
    Kawaguchi J; Hamatani Y; Hirayama A; Nishimura K; Nakai E; Nakamura E; Miyata M; Kawano Y; Takada Y; Anchi Y; Funabashi S; Kuroda K; Azechi M; Takahama H; Anzai T; Yasuda S; Kitaoka H; Izumi C
    J Cardiol; 2020 Jun; 75(6):682-688. PubMed ID: 32061472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioids for the palliation of refractory breathlessness in adults with advanced disease and terminal illness.
    Barnes H; McDonald J; Smallwood N; Manser R
    Cochrane Database Syst Rev; 2016 Mar; 3(3):CD011008. PubMed ID: 27030166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of moderate-to-severe dyspnea in hospitalized patients receiving palliative care.
    Gomutbutra P; O'Riordan DL; Pantilat SZ
    J Pain Symptom Manage; 2013 May; 45(5):885-91. PubMed ID: 22940561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of diagnostic and treatment approaches to acute dyspnea in a palliative care setting among medical doctors with different educational levels.
    Hackner K; Heim M; Masel EK; Riedl G; Weber M; Strieder M; Danninger S; Pecherstorfer M; Kreye G
    Support Care Cancer; 2022 Jul; 30(7):5759-5768. PubMed ID: 35338391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioids for treating refractory dyspnea in patients with heart failure: A protocol for systematic review and meta-analysis.
    Lyu J; Sun X; Chen M; Li S
    Medicine (Baltimore); 2022 Nov; 101(47):e31699. PubMed ID: 36451406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is there a higher risk of respiratory depression in opioid-naïve palliative care patients during symptomatic therapy of dyspnea with strong opioids?
    Clemens KE; Quednau I; Klaschik E
    J Palliat Med; 2008 Mar; 11(2):204-16. PubMed ID: 18333735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioids for Relief of Dyspnea Immediately Before Death in Patients With Noncancer Disease: A Case Series Study.
    Murakami M
    Am J Hosp Palliat Care; 2019 Aug; 36(8):734-739. PubMed ID: 30803242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response to Oral Immediate-Release Opioids for Breakthrough Pain in Patients with Advanced Cancer with Adequately Controlled Background Pain.
    Azhar A; Kim YJ; Haider A; Hui D; Balankari VR; Epner MC; Park M; Liu DD; Williams J; Frisbee-Hume SE; Allo JA; Bruera E
    Oncologist; 2019 Jan; 24(1):125-131. PubMed ID: 30254187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials.
    Gheorghiade M; Konstam MA; Burnett JC; Grinfeld L; Maggioni AP; Swedberg K; Udelson JE; Zannad F; Cook T; Ouyang J; Zimmer C; Orlandi C;
    JAMA; 2007 Mar; 297(12):1332-43. PubMed ID: 17384438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in Dyspnea Status During Hospitalization and Postdischarge Health-Related Quality of Life in Patients Hospitalized for Heart Failure: Findings From the EVEREST Trial.
    Ambrosy AP; Khan H; Udelson JE; Mentz RJ; Chioncel O; Greene SJ; Vaduganathan M; Subacuis HP; Konstam MA; Swedberg K; Zannad F; Maggioni AP; Gheorghiade M; Butler J
    Circ Heart Fail; 2016 May; 9(5):. PubMed ID: 27140204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial.
    Konstam MA; Gheorghiade M; Burnett JC; Grinfeld L; Maggioni AP; Swedberg K; Udelson JE; Zannad F; Cook T; Ouyang J; Zimmer C; Orlandi C;
    JAMA; 2007 Mar; 297(12):1319-31. PubMed ID: 17384437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A critical review of the respiratory benefits and harms of orally administered opioids for dyspnea management in COPD.
    Vozoris NT
    Expert Rev Respir Med; 2021 Dec; 15(12):1579-1587. PubMed ID: 34761704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness and safety of opioids for dyspnea in patients with lung cancer: secondary analysis of multicenter prospective observational study.
    Taniguchi Y; Matsuda Y; Mori M; Ito M; Ikari T; Tokoro A; Aiki S; Hoshino S; Kiuchi D; Suzuki K; Igarashi Y; Odagiri T; Oya K; Kubo E; Yamaguchi T
    Transl Lung Cancer Res; 2022 Dec; 11(12):2395-2402. PubMed ID: 36636410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opioids for the Management of Dyspnea in Cancer Patients: Evidence of the Last 15 Years--A Systematic Review.
    Vargas-Bermúdez A; Cardenal F; Porta-Sales J
    J Pain Palliat Care Pharmacother; 2015; 29(4):341-52. PubMed ID: 26523974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attitudes toward opioids for refractory dyspnea in COPD among Dutch chest physicians.
    Janssen DJ; de Hosson SM; bij de Vaate E; Mooren KJ; Baas AA
    Chron Respir Dis; 2015 May; 12(2):85-92. PubMed ID: 25676931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visualizing How to Use Parenteral Opioids for Terminal Cancer Dyspnea: A Pilot, Multicenter, Prospective, Observational Study.
    Mori M; Kawaguchi T; Imai K; Yokomichi N; Yamaguchi T; Suzuki K; Matsunuma R; Watanabe H; Maeda I; Matsumoto Y; Matsuda Y; Morita T;
    J Pain Symptom Manage; 2021 Nov; 62(5):936-948. PubMed ID: 33992759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioids in patients with COPD and refractory dyspnea: literature review and design of a multicenter double blind study of low dosed morphine and fentanyl (MoreFoRCOPD).
    van Dijk M; Mooren KJM; van den Berg JK; van Beurden-Moeskops WJC; Heller-Baan R; de Hosson SM; Lam-Wong WY; Peters L; Pool K; Kerstjens HAM
    BMC Pulm Med; 2021 Sep; 21(1):289. PubMed ID: 34507574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioids for symptomatic therapy of dyspnoea in patients with advanced chronic heart failure--is there evidence?
    Hochgerner M; Fruhwald FM; Strohscheer I
    Wien Med Wochenschr; 2009 Dec; 159(23-24):577-82. PubMed ID: 20151346
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.